Access to the PPM Journal and newsletters is FREE for clinicians.
Signup for PPM

Opioid Use Disorder (OUD)

PEMF that activates brainwaves associated with contentment may reduce common opioid withdrawal symptoms.
Jennifer Schneider MD, PhD, digs into a common—and frustrating—misunderstanding in pain medicine terminology.
With addiction rising, demand for formulations such as buprenorphine (Probuphine) to aid in opioid addiction treatment (MAT) continues to grow.
Critical disparities identified among patient population groups.
Partial agonists such as buprenorphine may offer an effective opioid alternative for pain management.
ANS-6637 may reduce “surges” without affecting dopamine brain levels.
Improvised devices are typically used as quick-acting options for the untrained.
Inside the pharmacodynamics and presentation of loperamide including potential abuse and related patient behaviors.
Withdrawal and craving scores for the buprenorphine product remained constant and consistently lower than placebo.
Recently FDA-approved, reSET-O encourages CBT guidelines to coincide with opioid use disorder treatment.
President Trump established a new commission to combat opioid addiction, taps Governor Chris Christie to head--Practical Pain Management gets reaction from physicians in the field.
Drug-seeking behaviors may be very similar to those presented in patients with inadequately controlled pain.
New research suggests that deep brain stimulation of the brain (subthalamic nucleus) may reduce heroin abuse in an animal model.
Survey finds that many clinicians have negative attitudes about opioid addiction, often blaming the patient. Learn more about the new national survey.
Experts answer the question: Can Butrans be used for opioid addiction?
Chronic pain and addiction are frequent comorbidities, creating a therapeutic dilemma for many pain specialists.
close X